Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• mAb Production
• Protein Characterization
• Protein Detection
• Protein Production
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• Feature Articles: Seasoned Drugs Offer Therapeutic Gold Mine
  
• BioPerspectives: Drug Repurposing Rekindles Promise
  In addition to providing new treatments, repurposing can aid in dissecting complex disorders, discovering molecular targets, and unraveling disease processes.
• Feature Articles: De-Risking Clinical Development
  Best Bet May Be to Repurpose a Well-Defined Drug with Proven Safety and Utility in Humans
• Feature Articles: Systems Biology Upends Drug Reprofiling
  Rational Method Has Considerable Advantages over Shotgun Approach
• Feature Articles: Drug Repositioning Gains in Popularity
  Strategy Is in Vogue from Large Pharma Companies to Biotechs and Foundations

• Insight & Intelligence™

• More »

• NCATS, MRC Take Aim at Teaching Old Drugs New Tricks
  June 5, 2012
  U.S. repurposing initiative counts on industry more than U.K.’s, in which only academics can apply for grants.

• GEN News Highlights

• More »

• Potential Prion Disease Therapy Uncovered
  
• Hope for Autism Lies in Century-Old Drug
  
• Old Drug Plays New Tricks on Diabetes and Obesity
  
• Consortium Launches €196M Drug Discovery "Factory"
  
• Roche, Broad Institute Seek New Uses for Old Drugs
  

• GEN Podcasts

• More »

• Drug Repositioning as a Viable Business Model
  Aris Persidis, Ph.D., President, Biovista